Drug
Incb161734
Incb161734: highest development phase Phase 3, developed by Incyte. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Incyte
Trials
| Drug | Phase | Indication |
|---|---|---|
| INCB161734 NCT07522073 | Phase 3 | Solid Tumors |
| INCB161734 NCT07814404 | Phase 1 | |
| INCB161734 NCT07853040 | Phase 1 | Hepatic Insufficiency |
Latest
No recent events.
Follow Incb161734 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.